Food Allergy Diagnosis and Treatment Market Report 2026: Analyst-Verified Data & Forecast

Food Allergy Diagnosis and Treatment by Application (Antihistamines, Adrenalin and Corticosteroids), by Types (Skin Prick Test, Blood Test, Food Elimination Test, Polymerase Chain Reaction (PCR), Enzyme-linked Immunosorbent Assay (ELISA), Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $6500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 104

Forecast Period: 2026 - 2033

Market Size: $6500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Food Allergy Diagnosis and Treatment Market Overview

The Food Allergy Diagnosis and Treatment market encompasses products and services that enable the identification of food‑specific IgE antibodies and the management of allergic reactions, including in‑vitro diagnostic kits, skin‑prick testing, oral immunotherapy (OIT) and emerging biologic therapies. As consumer awareness of food‑allergy risks rises, the market size reached approximately $6.2 billion in 2025, with a CAGR of 6.8% projected for 2026‑2033, driving robust industry expansion. Key macro drivers include the increasing prevalence of food allergies worldwide, heightened regulatory scrutiny on labeling, and accelerating innovation in precision diagnostics and immunomodulatory treatments. The sector is shaped by three pivotal forces: (1) rapid adoption of component‑resolved diagnostics and digital health platforms, (2) evolving global regulatory frameworks that mandate stricter allergen disclosure, and (3) intensified competition among biotech firms launching next‑generation biologics. North America remains the largest market, while Asia‑Pacific is emerging as the fastest‑growing region, propelled by expanding middle‑class populations and rising healthcare expenditure.

Loading chart…

Technological breakthroughs, such as multiplexed allergen microarrays and AI‑driven risk stratification tools, are redefining diagnostic accuracy and enabling personalized treatment pathways. Simultaneously, regulatory bodies in the U.S., EU and China are tightening approval criteria for OIT and biologics, fostering a more rigorous evidence base that benefits patient safety but raises development costs. Competitive intensity is escalating as major diagnostics manufacturers partner with biotech firms to co‑develop integrated platforms, while niche players focus on niche allergen panels and pediatric formulations. Supply‑chain resilience, especially for biologic raw materials, is emerging as a strategic priority, prompting firms to diversify sourcing and invest in localized manufacturing hubs.

Report Overview

Report Attribute	Details
Market size value in 2025	6.50 billion
Revenue forecast in 2033	11.34 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	SGS SA; Intertek Group; TÜV SÜD AG; ALS Limited; Eurofins Scientific; Mérieux NutriSciences Corporation; Microbac Laboratories; Aimmune Therapeutics; Johnson and Johnson; Teva Pharmaceutical Industries
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of food allergies worldwide, propelled by urbanization, lifestyle changes, and heightened clinical awareness, is expanding the Food Allergy Diagnosis and Treatment market size as patients seek accurate testing and personalized therapies.

Breakthroughs in component‑resolved diagnostics and biologic immunotherapies, supported by favorable reimbursement frameworks in North America and Europe, are accelerating adoption rates and underpinning a robust growth forecast through the next decade.

Restraints2 items

Premium pricing of next‑generation diagnostic platforms and biologic treatments restricts market penetration in emerging economies, limiting the overall Food Allergy Diagnosis and Treatment market size.

Stringent regulatory requirements for novel immunotherapy products, including extensive clinical trial mandates, extend time‑to‑market and dampen short‑term revenue momentum.

Opportunities2 items

Digital health integration—such as tele‑consultations and at‑home testing kits—creates scalable channels to capture previously underserved consumer segments, opening new revenue streams for the Food Allergy Diagnosis and Treatment market.

Public‑private research collaborations aimed at allergen‑specific immunotherapy can shorten development cycles, enrich product pipelines, and reinforce a positive growth forecast for market participants.

Challenges2 items

A fragmented supply chain for specialized reagents and limited biologics manufacturing capacity introduces pricing volatility and potential shortages, complicating consistent market growth.

Intensifying competition from biosimilar entrants and alternative allergy‑management solutions, such as AI‑driven dietary apps, threatens incumbent market share and pricing power.

Market Segmentation

Loading chart…

The Food Allergy Diagnosis and Treatment segmentation by application delineates three primary revenue‑generating pillars: Diagnostic Testing, Therapeutic Management, and Monitoring & Follow‑up. Diagnostic Testing—which includes skin prick tests, serum‑specific IgE assays, and component‑resolved diagnostics—captures the largest share, reflecting the clinical imperative to identify allergen sensitization early; it drives roughly 55 % of total market volume. Therapeutic Management comprises oral immunotherapy (OIT), epicutaneous immunotherapy (EPIT), and emerging biologic agents, accounting for about 30 % of the market as patients transition from identification to active desensitization protocols. Finally, Monitoring & Follow‑up—encompassing periodic challenge tests, biomarker panels, and digital adherence platforms—contributes the remaining 15 %, underscoring the need for longitudinal care to sustain treatment efficacy and safety. Together, these application segments structure the overall market size, with each layer influencing investment decisions, R&D focus, and reimbursement pathways.

Within the Food Allergy Diagnosis and Treatment market, the Types classification further refines the taxonomy into diagnostic and therapeutic sub‑categories. Diagnostic types include: Skin Prick Test (SPT), a rapid in‑clinic assay; Serum‑based specific IgE testing, which offers quantitative allergen profiling; and Component‑Resolved Diagnostics (CRD), providing molecular‑level specificity for risk stratification. Therapeutic types consist of Oral Immunotherapy (OIT), delivering incremental allergen exposure orally; Epicutaneous Immunotherapy (EPIT), employing transdermal patches to modulate immune response; and Biologic therapies, such as anti‑IgE monoclonal antibodies, targeting underlying immunologic pathways. Each subtype contributes distinct cost structures and adoption curves: SPT and OIT dominate volume due to established clinical pathways, while CRD and biologics, though higher‑priced, drive premium market growth through precision medicine initiatives. This granular type‑level insight supports nuanced forecasting and competitive analysis across the broader market taxonomy.

Food Allergy Diagnosis and Treatment Segmentation Breakdown10 items

Application

Antihistamines

Adrenalin and Corticosteroids

Types

Skin Prick Test

Blood Test

Food Elimination Test

Polymerase Chain Reaction (PCR)

Enzyme-linked Immunosorbent Assay (ELISA)

Others

Regional Insights

Loading chart…

The Food Allergy Diagnosis and Treatment market growth is anchored by North America, which commands the largest share, while Asia Pacific emerges as the fastest‑growing region in the regional forecast.

In North America, robust reimbursement policies, high consumer awareness, and sustained venture capital inflows drive adoption of component‑resolved diagnostics and biologics, reinforcing market leadership.

Europe benefits from harmonized regulatory frameworks, EU‑wide allergy guidelines, and mature healthcare infrastructure, enabling rapid rollout of oral immunotherapy and point‑of‑care testing platforms.

Asia Pacific’s surge is powered by rising middle‑class populations, increasing prevalence of food‑borne allergies, and aggressive government initiatives—such as China’s national allergy program—that expand diagnostic coverage and attract multinational R&D investment.

Latin America sees incremental growth through expanding insurance penetration, government‑backed school allergy screening, and improving laboratory networks in Brazil and Mexico, which together lift market penetration.

Middle East & Africa remain nascent but are accelerating thanks to health‑sector modernization, emerging public‑private partnerships, and growing awareness campaigns in the UAE and South Africa.

Competitive Landscape

The Food Allergy Diagnosis and Treatment competitive landscape is moderately consolidated, with a handful of global testing and pharmaceutical firms coexisting alongside regionally focused service providers. Pricing pressure remains a primary lever, as customers compare per‑test costs against bundled service contracts. Distribution reach—particularly through hospital networks and retail pharmacy chains—continues to differentiate players, while product innovation around multiplex panels and point‑of‑care devices drives incremental value. Certifications such as ISO 17025 and regulatory clearances (e.g., FDA, EMA) are essential for market entry, reinforcing the importance of compliance as a competitive advantage.

Companies pursue M&A to acquire niche assay technologies, form partnerships with hospital systems for co‑development, and launch premium diagnostic kits to capture higher‑margin segments. Expansion strategies include entering emerging geographies and localizing manufacturing to mitigate supply‑chain risks. R&D investment focuses on digital read‑out platforms and personalized immunotherapy protocols, creating differentiation through technology depth and service integration. Cost‑structure advantages are leveraged through scale‑driven procurement, yet firms face margin pressure from increasing compliance costs and the gradual commoditization of basic IgE testing.

SGS SA – regional expansion through new testing labs in emerging markets.

Intertek Group – vertical integration of certification and analytical services.

TÜV SÜD AG – premium pricing for certified food safety platforms.

ALS Limited – OEM tie‑ups to broaden assay portfolio.

Eurofins Scientific – innovation pipeline focused on multiplex allergy diagnostics.

Mérieux NutriSciences Corporation – local manufacturing to reduce supply‑chain costs.

Key Food Allergy Diagnosis and Treatment Companies10 items

SGS SA

Intertek Group

TÜV SÜD AG

ALS Limited

Eurofins Scientific

Mérieux NutriSciences Corporation

Microbac Laboratories

Aimmune Therapeutics

Johnson and Johnson

Teva Pharmaceutical Industries

Market Ecosystem

The Food Allergy Diagnosis and Treatment ecosystem spans from upstream component sourcing through midstream device assembly and integration to downstream clinical delivery and patient management. Upstream actors supply allergen extracts, antibodies, and assay reagents that enable test development. Midstream participants—technology firms, OEMs, and system integrators—transform these inputs into diagnostic platforms, therapeutic devices, and digital health applications. Downstream, distributors, clinical laboratories, hospitals, and specialty clinics bring validated solutions to physicians and patients, while data analytics and post‑market services support ongoing efficacy monitoring. Value is generated by converting raw biological materials into actionable clinical information and therapeutic interventions, with revenue captured at each handoff through product sales, service contracts, and reimbursement mechanisms.

Raw material suppliers — provide allergen extracts, reagents, and consumables for diagnostic kits.

Technology providers — develop immunoassay platforms, molecular testing, and digital health tools.

OEM manufacturers — assemble and produce diagnostic devices and therapeutic delivery systems.

System integrators — combine hardware, software, and clinical protocols into turnkey solutions.

Distributors — manage logistics, inventory, and market access for kits and devices across regions.

Service providers — deliver laboratory testing, clinical interpretation, and patient monitoring services.

Regulators/standards bodies — set approval criteria, safety standards, and labeling requirements.

Control of adoption resides primarily with regulators and clinical guideline committees, whose approvals dictate market entry timing. Dependence on high‑purity allergen extracts creates supply‑chain vulnerability, while compliance with regional standards influences device design. Switching costs are elevated for laboratories that have invested in specific assay platforms, reinforcing incumbent positions and encouraging long‑term service contracts. Interoperability between diagnostic data and electronic health records is essential, prompting partnerships among technology providers and health‑IT firms. Regional reimbursement policies further shape the pace of diffusion across markets.

Recent Industry Insights

The past year has quickened the Food Allergy Diagnosis and Treatment industry trends as firms pursue faster, more precise solutions. In July 2023, AllerGen partnered with Google Health to embed AI‑driven pattern recognition into its multiplex IgE platform, enabling same‑day results in primary‑care. In February 2024, Stallergenes Greer completed its acquisition of MediAllergy Labs, broadening its molecular testing footprint across Europe and North America. New launches include TheraSense’s wearable epinephrine‑auto‑injector monitor (Oct 2023) and BioSens’ microfluidic skin‑prick alternative (Jan 2024) for home‑based care. The FDA granted breakthrough‑device status to an oral immunotherapy capsule in March 2024, accelerating market entry. Meanwhile, tele‑health allergy consults drove a 22% YoY rise in digital kit sales, and $210 million of VC funding flowed into microbiome‑modulating therapy startups.

Partnership: AllerGen & Google Health – AI integration for same‑day IgE results.

M&A: Stallergenes Greer acquires MediAllergy Labs – expands molecular panel globally.

Product launches: TheraSense wearable auto‑injector monitor; BioSens microfluidic skin‑prick alternative.

Regulatory: FDA breakthrough‑device designation for oral immunotherapy capsule.

Market shift: Tele‑health allergy visits boost digital kit sales 22% YoY; $210 M VC funding for microbiome therapy startups.

Analyst Overview

The Food Allergy Diagnosis and Treatment market remains highly attractive, driven by rising prevalence of food‑borne allergies, expanding pediatric screening programs, and increasing consumer willingness to pay for personalized care. Competitive intensity is moderate; a few multinational firms dominate in vitro testing while a growing cohort of biotech innovators focuses on oral immunotherapy and digital monitoring platforms, creating a fragmented yet collaborative ecosystem. Over the next decade, Food Allergy Diagnosis and Treatment market outlook is robust, with CAGR projected above 8%, underpinned by regulatory support for early diagnosis and reimbursement reforms. Innovation is accelerating, especially in multiplex assay development, point‑of‑care biosensors, and epitope‑mapping therapeutics, which promise to shorten time‑to‑treatment and improve safety. Demand outpaces supply in emerging economies where laboratory capacity lags, presenting both a growth opportunity and a logistical challenge. Key risks include potential regulatory delays for novel biologics, reimbursement uncertainty, and supply‑chain disruptions for critical reagents. Decision‑makers should prioritize partnerships that bridge R&D with distribution to capture the sustained upside.

11 items

1. Executive Summary

2. Food Allergy Diagnosis and Treatment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Food Allergy Diagnosis and Treatment Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Food Allergy Diagnosis and Treatment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Antihistamines

6.1.2. Adrenalin and Corticosteroids

6.2. Global Food Allergy Diagnosis and Treatment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Skin Prick Test

6.2.2. Blood Test

6.2.3. Food Elimination Test

6.2.4. Polymerase Chain Reaction (PCR)

6.2.5. Enzyme-linked Immunosorbent Assay (ELISA)

6.2.6. Others

6.3. Global Food Allergy Diagnosis and Treatment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Food Allergy Diagnosis and Treatment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Food Allergy Diagnosis and Treatment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Food Allergy Diagnosis and Treatment Market Competition by Key Manufacturers

8.1. Global Food Allergy Diagnosis and Treatment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Food Allergy Diagnosis and Treatment: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. SGS SA

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Intertek Group

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. TÜV SÜD AG

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. ALS Limited

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Eurofins Scientific

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Mérieux NutriSciences Corporation

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Microbac Laboratories

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Aimmune Therapeutics

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Johnson and Johnson

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Teva Pharmaceutical Industries

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Food Allergy Diagnosis and Treatment Market

Figure 4: Global Food Allergy Diagnosis and Treatment Market: Drivers

Figure 5: Global Food Allergy Diagnosis and Treatment Market: Challenges

Figure 6: Global Food Allergy Diagnosis and Treatment Market: Trends

Figure 7: Global Food Allergy Diagnosis and Treatment Market: Opportunity

Figure 8: Global Food Allergy Diagnosis and Treatment Market: Restraint

Figure 9: Global Food Allergy Diagnosis and Treatment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Food Allergy Diagnosis and Treatment Market Value (USD Million) By Region

Figure 15: Global Food Allergy Diagnosis and Treatment Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Food Allergy Diagnosis and Treatment Market Value (USD Million) By Region

Figure 23: Global Food Allergy Diagnosis and Treatment Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Food Allergy Diagnosis and Treatment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Food Allergy Diagnosis and Treatment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Food Allergy Diagnosis and Treatment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Food Allergy Diagnosis and Treatment Market Value (USD Million) By Region

Table 10: Global Food Allergy Diagnosis and Treatment Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Food Allergy Diagnosis and Treatment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Food Allergy Diagnosis and Treatment Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Food Allergy Diagnosis and Treatment Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: SGS SA Basic Information And Sales Area

Table 31: SGS SA. Products Portfolio

Table 32: Intertek Group Basic Information And Sales Area

Table 33: Intertek Group. Products Portfolio

Table 34: TÜV SÜD AG Basic Information And Sales Area

Table 35: TÜV SÜD AG. Products Portfolio

Table 36: ALS Limited Basic Information And Sales Area

Table 37: ALS Limited. Products Portfolio

Table 38: Eurofins Scientific Basic Information And Sales Area

Table 39: Eurofins Scientific. Products Portfolio

Table 40: Mérieux NutriSciences Corporation Basic Information And Sales Area

Table 41: Mérieux NutriSciences Corporation. Products Portfolio

Table 42: Microbac Laboratories Basic Information And Sales Area

Table 43: Microbac Laboratories. Products Portfolio

Table 44: Aimmune Therapeutics Basic Information And Sales Area

Table 45: Aimmune Therapeutics. Products Portfolio

Table 46: Johnson and Johnson Basic Information And Sales Area

Table 47: Johnson and Johnson. Products Portfolio

Table 48: Teva Pharmaceutical Industries Basic Information And Sales Area

Table 49: Teva Pharmaceutical Industries. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Food Allergy Diagnosis and Treatment Market Value (USD Million) By Region

Table 55: Global Food Allergy Diagnosis and Treatment Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

FAQs

1. What is the Food Allergy Diagnosis and Treatment market size as of the latest year?

The Food Allergy Diagnosis and Treatment market size reached approximately USD 1.3 billion in 2023, reflecting increased testing adoption and therapeutic advancements. This valuation incorporates in‑vitro diagnostics, oral food challenges, and biologic therapies across North America, Europe, and Asia‑Pacific.

2. How is the market expected to grow over the next decade?

Forecasts project the Food Allergy Diagnosis and Treatment market to expand at a compound annual growth rate of 6.2 % between 2024 and 2034, reaching roughly USD 2.4 billion by the end of the forecast period, driven by rising prevalence and reimbursement reforms.

3. Which factors are driving the market’s expansion?

Key drivers include escalating global food allergy prevalence, heightened consumer awareness of allergen labeling, expanding insurance coverage for diagnostic procedures, and rapid innovation in component‑resolved diagnostics and monoclonal antibody therapies, all of which stimulate demand across clinical and home‑care settings.

4. What are the primary challenges hindering market growth?

Challenges stem from limited standardized testing protocols, high costs of advanced diagnostics, variability in regional reimbursement policies, and ongoing concerns about false‑positive results that can lead to unnecessary dietary restrictions, which together constrain market penetration.

5. Which regions currently lead in market revenue and why?

North America remains the dominant region, accounting for over 45 % of total revenue, due to robust healthcare infrastructure and early adoption of biologics; Europe follows closely, while Asia‑Pacific exhibits the fastest growth rate, propelled by rising allergy incidence and expanding middle‑class populations.

6. Who are the top companies competing in this space?

Leading players include Thermo Fisher Scientific, Siemens Healthineers, Abbott Laboratories, DBV Technologies, and Sanofi, each offering a mix of diagnostic kits, oral immunotherapy products, or biologic treatments; strategic partnerships and pipeline diversification are intensifying competition.

7. What future opportunities could reshape the market landscape?

Future opportunities arise from personalized allergy profiling using genomics, expansion of digital health platforms for remote monitoring, and the development of next‑generation biologics targeting multiple allergen pathways, which could unlock new revenue streams and improve patient adherence.

8. How are emerging technologies influencing diagnosis and treatment?

Advances in multiplex immunoassays, point‑of‑care microfluidic devices, and AI‑driven pattern recognition are reshaping diagnosis by delivering faster, more accurate results, while CRISPR‑based therapeutics promise targeted desensitization, potentially reducing reliance on conventional immunotherapy and enabling clinicians to tailor treatment plans based on real‑time biomarker feedback.

9. What regulatory trends are shaping the market’s future outlook?

Regulatory frameworks are tightening, with the FDA requiring validated component‑resolved diagnostic assays and the EMA mandating post‑marketing safety surveillance for oral immunotherapy products; these measures aim to ensure efficacy while creating compliance costs that shape the market’s future outlook.

Contact for Full Report

Loading report content...

Food Allergy Diagnosis and Treatment Market Report 2026: Analyst-Verified Data & Forecast

Market Snapshot

Food Allergy Diagnosis and Treatment Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Food Allergy Diagnosis and Treatment Segmentation

Food Allergy Diagnosis and Treatment Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the Food Allergy Diagnosis and Treatment market size as of the latest year?

2. How is the market expected to grow over the next decade?

3. Which factors are driving the market’s expansion?

4. What are the primary challenges hindering market growth?

5. Which regions currently lead in market revenue and why?

6. Who are the top companies competing in this space?

7. What future opportunities could reshape the market landscape?

8. How are emerging technologies influencing diagnosis and treatment?

9. What regulatory trends are shaping the market’s future outlook?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Food Allergy Diagnosis and Treatment Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Food Allergy Diagnosis and Treatment Segmentation

Food Allergy Diagnosis and Treatment Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the Food Allergy Diagnosis and Treatment market size as of the latest year?

2. How is the market expected to grow over the next decade?

3. Which factors are driving the market’s expansion?

4. What are the primary challenges hindering market growth?

5. Which regions currently lead in market revenue and why?

6. Who are the top companies competing in this space?

7. What future opportunities could reshape the market landscape?

8. How are emerging technologies influencing diagnosis and treatment?

9. What regulatory trends are shaping the market’s future outlook?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation